RJA
ATHN

Raymond James & Associates’s Athenahealth, Inc. ATHN Stock Holding History

Raymond James & Associates’s Portfolio ATHN Stock Details ATHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4,686
Closed -$618K – 3770
2018
Q4 		$618K Sell
4,686
-823
-15% -$105K ﹤0.01% 2402
2018
Q3 		$736K Sell
5,509
-7,999
-59% -$1.2M ﹤0.01% 2438
2018
Q2 		$2.15M Buy
13,508
+2,586
+24% +$384K ﹤0.01% 1714
2018
Q1 		$1.56M Buy
10,922
+8,006
+275% +$1.09M ﹤0.01% 1849
2017
Q4 		$388K Buy
2,916
+101
+4% +$12.9K ﹤0.01% 2691
2017
Q3 		$350K Sell
2,815
-1,064
-27% -$147K ﹤0.01% 2692
2017
Q2 		$545K Buy
3,879
+86
+2% +$10.7K ﹤0.01% 2361
2017
Q1 		$427K Buy
+3,793
New +$442K ﹤0.01% 2482
2016
Q4 		– Sell
-2,132
Closed -$269K – 3416
2016
Q3 		$269K Buy
+2,132
New +$271K ﹤0.01% 2691

Raymond James & Associates's ATHN Position: Q1 2019 in Review

Raymond James & Associates sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 4,686 shares — an estimated $618K sold.

Raymond James & Associates first reported a position in ATHN in Q3 2016 and held it in 9 quarters. The position peaked at $2.15M in Q2 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • Raymond James & Associates reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • Raymond James & Associates sold 4,686 Athenahealth, Inc. shares in Q1 2019, an estimated $618K.
  • Raymond James & Associates first reported a position in Athenahealth, Inc. in Q3 2016 and held it in 9 quarters.
  • Raymond James & Associates's Athenahealth, Inc. position peaked at $2.15M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Raymond James & Associates's 13F filing for Q1 2019, filed 6 May 2019.